Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1006742

C(c1ccccc1)=[Ru+2](=C1N(C2CCCCC2)CCN1C1CCCCC1)=C1N(C2CCCCC2)CCN1C1CCCCC1.[Cl-].[Cl-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.39
SLC18A3 Q16572 1/20 0.39
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OGFRL1 Q5TC84 1/20 0.35
LMNA P02545 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
CHRNA7 P36544 1/20 0.35
HRH3 Q9Y5N1 2/20 0.33
POLB P06746 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1006782 0.76 SLC18A3 (0.35) SLC18A3NPSR1GAAALDH1A1KDM4E
SCHEMBL4607065 0.71 HSD11B1 (0.39) HSD11B1SLC18A3HPGDGAAALDH1A1
Hydrochloric Acid SCHEMBL852064 0.70 HSD11B1 (0.38) HSD11B1SLC18A3HPGDGAAALDH1A1
SCHEMBL819176 0.69 HSD11B1 (0.38) HSD11B1SLC18A3HPGDGAAALDH1A1
Hydrochloric Acid SCHEMBL1007232 0.68 HSD11B1 (0.35) HSD11B1SLC18A3HPGDGAAALDH1A1
Hydrochloric Acid SCHEMBL6100085 0.66 HSD11B1 (0.33) HSD11B1SLC18A3HPGDNPSR1GAA
SCHEMBL28898023 0.64 HSD11B1 (0.34) HSD11B1SLC18A3HPGDGAAALDH1A1
Hydrochloric Acid SCHEMBL1172655 0.64 KDM4E (0.34) SLC18A3NPSR1GAAALDH1A1KDM4E
SCHEMBL12230209 0.61 SLC18A3 (0.50) SLC18A3ALDH1A1KDM4ELMNAHRH3
SCHEMBL1043568 0.61 OPRM1 (0.43) HSD11B1SLC18A3GAAOPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250215136-A1 RUBBER COMPOSITION AND CROSSLINKED RUBBER PRODUCT ZEON CORPORATION (JP) 2025-07-03 US disclosed
US-20250215137-A1 COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER ZEON CORPORATION (JP) 2025-07-03 US disclosed
US-20250091969-A1 CYCLOPENTENE RECOVERY METHOD ZEON CORPORATION (JP) 2025-03-20 US disclosed
EP-4502014-A1 COPOLYMER, RUBBER COMPOSITION AND CROSSLINKED RUBBER Zeon Corporation (JP) 2025-02-05 EP disclosed
EP-4502059-A1 RUBBER COMPOSITION AND CROSSLINKED RUBBER PRODUCT Zeon Corporation (JP) 2025-02-05 EP disclosed
WO-2025013873-A1 CYCLOPENTENE RECOVERY METHOD 日本ゼオン株式会社 2025-01-16 WO disclosed
EP-4461720-A1 CYCLOPENTENE RECOVERY METHOD Zeon Corporation (JP) 2024-11-13 EP disclosed
WO-2023132366-A1 CYCLOPENTENE RECOVERY METHOD 日本ゼオン株式会社 2023-07-13 WO disclosed
US-9570641-B2 Polymer and solar cell encapsulant using the polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-14 US disclosed
EP-2270063-B1 PROCESS FOR PRODUCING HYDROGENATED PRODUCT OF CYCLIC OLEFIN POLYMER PREPARED THROUGH RING-OPENING POLYMERIZATION ZEON CORP (JP) 2016-03-23 EP disclosed
EP-1589055-A1 PROCESS FOR PRODUCING CYCLOOLEFIN RESIN FILM AND PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER SHEET OR FILM Zeon Corporation (JP) 2005-10-26 EP disclosed
US-20050148746-A1 Norbornene-based ring-opening polymerization polymer, product of hydrogenation of norbornene-based ring-opening polymerization polymer, and processes for producing these ZEON CORPORATION (JP) 2005-07-07 US disclosed
US-6908970-B2 Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization ZEON CORPORATION (JP) 2005-06-21 US disclosed
EP-1535941-A1 PROCESSES FOR PRODUCING THERMOPLASTIC RESINS, CROSSLINKED RESINS AND CROSSLINKED RESIN COMPOSITE MATERIALS ZEON CORPORATION (JP) 2005-06-01 EP disclosed
US-6815516-B2 HEAT RESISTANCE, SOLVENT SOLUBILITY ZEON CORPORATION (JP) 2004-11-09 US disclosed
US-20030050406-A1 Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization ZEON CORPORATION 2003-03-13 US disclosed
US-20030018138-A1 Copolymer formed by ring -opening polymerization, product of hydrogenation of copolymer formed by ring-opening polymerization, and process for producing these ZEON CORPORATION (JP) 2003-01-23 US disclosed
EP-1275675-A1 COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, PRODUCT OF HYDROGENATION OF COPOLYMER FORMED BY RING-OPENING POLYMERIZATION, AND PROCESSES FOR PRODUCING THESE Zeon Corporation (JP) 2003-01-15 EP disclosed
US-6486264-B1 Process for producing hydrogenated ring-opening polymerization polymer of cycloolefin ZEON CORPORATION (JP) 2002-11-26 US disclosed
EP-1197509-A1 PROCESS FOR PRODUCING HYDROGENATED RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN Nippon Zeon Co., Ltd. (JP) 2002-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091969-A1 CYCLOPENTENE RECOVERY METHOD CYC1, CYCS, DHPS HSD11B1 310/4885SLC18A3 3263/4885HPGD 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.